FIT checks for blood in the stool, which can indicate the presence of colorectal cancer or polyps. Patients collect stool ...

Pharmacy-based CRC screening programs using FIT can improve early detection, especially in underserved communities, with effective follow-up care. Patients prefer digital updates for negative results ...

People invited to undergo FIT were more likely to participate in colorectal cancer screening compared with those invited to undergo colonoscopy. FIT was noninferior to colonoscopy for colorectal ...

Millions remain unscreened for colorectal cancer. Learn how noninvasive screening can expand access, preserve capacity, and ...

Please provide your email address to receive an email when new articles are posted on . People in rural areas experience a variety of barriers to CRC screening. A mailed fecal immunochemical test ...

FIT outperformed cfDNA in detecting advanced precancerous colorectal lesions, showing higher sensitivity and specificity. Blood-based tests offer easier implementation and potentially higher adherence ...

Colorectal cancer incidence and mortality have increased among younger adults in recent years, with the most significant increase seen in those ages 40 to 49. Starting FIT screening early was tied to ...

The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer, NBC News reported. The test isn't meant to replace colonoscopies, but is ...